MedPath

A comparative study of efficacy of preoperative Dexmedotimidine nebulization with Magnesium sulphate nebulization in reducing post operative sore throat in patients undergoing general anaesthesia

Not yet recruiting
Conditions
Other specified symptoms and signsinvolving the circulatory and respiratory systems,
Registration Number
CTRI/2024/01/061491
Lead Sponsor
Department of Anaesthesiology
Brief Summary

This is a comparative study of preoperative Dexmedotimidine nebulization with Magnesium sulphate nebulization in reducing post operative sore throat in patients undergoing general anaesthesia for elective surgeries in KR Hospital, Mysuru.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

All ASA grade I and grade II patients between 19 to 60 years of age group of both sexes Mallampati grade 1 and 2 duration of surgery less than 2 hours Body mass index 25 to 30 kg/m2 Elective surgeries under general anasesthesia with endotracheal intubation and controlled ventilation.

Exclusion Criteria
  • Age <18 yeras and >60 years ALL ASA Grade III and above Mallampati grade III and above Patients with URTI, LRTI, Asthma, COPD, Smoking Difficult airway, who need nasogastric tube insertion.
  • Head and Neck surgeries, Emergency surgeries Patients who require more than one attempt of intubation and in whom the time taken for intubation is more than 20s.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Present or Absent24 hours
Post Operative Sore Throat24 hours
If present Grade 0 to 324 hours
Secondary Outcome Measures
NameTimeMethod
Adverse effects likenausea, vomiting, dry mouth, sedation0hr, 2hr, 6hr, 12hr, 24hrs

Trial Locations

Locations (1)

New stone building

🇮🇳

Mysore, KARNATAKA, India

New stone building
🇮🇳Mysore, KARNATAKA, India
Sindhu N P
Principal investigator
8150802056
sindhunp1@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.